ALS' (ASX:ALQ) expected improvement in sampling flows through the second half of fiscal 2025 and further improvement in fiscal 2026 could result in an upside to earnings outlook, Jarden Research said in a note Tuesday.
The company reported statutory earnings of AU$0.26 per share for the first half of the fiscal year 2025, down from AU$0.274 per share a year earlier. Revenue from ordinary activities rose nearly 20% to AU$1.46 billion from AU$1.22 billion a year earlier.
Jarden Research expects a 1% increase in the company's geochemistry sampling volumes and a further 2.8% improvement in fiscal 2026.
"We expect this could be a positive upside risk to our earnings forecasts, all else remaining equal," the investment firm said.
Jarden Research downgraded ALS to neutral from overweight and raised the target price to AU$14.40 from AU$14.25.
The company shares rose over 1% in recent Thursday trade.
Price (AUD): $15.51, Change: $+0.18, Percent Change: +1.14%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。